Cc1c(CCC(=O)NCCCn2ccnc2)c(=O)oc2c(C)c3occ(C(C)(C)C)c3cc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?